Details
Product Name in the RMS: Numeta G13E
MR Number: SE/H/0918/004
Date of outcome: 15.03.2016
Type of application | |
---|---|
Level 1: Level 2: Level 3: Level 4: Level 5: |
Line Extension Additional Strength/Form Fixed Combination Chemical Substance Prescription Only |
Active Substances |
alanine 4,66 g arginine 4,89 g aspartic acid 3,5 g calcium chloride dihydrate 3,45 g cysteine 1,1 g glucose monohydrate 550 g glutamic acid 5,83 g glycine 2,33 g histidine 2,21 g isoleucine 3,9 g leucine 5,83 g lysine 6,41 g MAGNESIUM ACETATE tetrahydrate 0,63 g methionine 1,4 g ornithine 1,45 g phenylalanine 2,45 g potassium acetate 3,83 g proline 1,75 g serine 2,33 g sodium glycerophosphate hydrate 6,15 g taurine 0,35 g threonine 2,16 g tryptophan 1,17 g tyrosine 0,45 g valine 4,43 g |
Form | Emulsion for infusion |
MA Holder in the RMS |
Baxter Medical AB, Sweden |
RMS | Sweden |
Date of last change | 28.12.2020 |
ATC-Code |
B05BA10 Combinations |
CMS Country | Domestic Product Name |
---|---|
Austria | Numeta G 13 % E Emulsion zur Infusion |
Belgium | Numetzah G13%E émulsion pour perfusion |
Czech Republic | Numeta G13%E |
Denmark | Numeta G13E |
Finland | |
France | |
Germany | Numeta G 13 % E |
Greece | NUMETA® PRETERM |
Ireland | |
Italy | |
Luxembourg | |
Malta | |
Netherlands | |
Norway | Numeta G13E |
Poland | |
Portugal | |
Spain | |
United Kingdom |
Documents | |
---|---|
PAR: | https://lakemedelsverket.se/LMF/Lakemedelsinformation/?nplid=20150326000025 (01.11.2016) |
PARSummary: | https://lakemedelsverket.se/LMF/Lakemedelsinformation/?nplid=20150326000025 (01.11.2016) |
FinalSPC: | https://lakemedelsverket.se/LMF/Lakemedelsinformation/?nplid=20150326000025&type=product (17.05.2016) |
FinalPL: | https://lakemedelsverket.se/LMF/Lakemedelsinformation/?nplid=20150326000025&type=product (17.05.2016) |